Q2 FY2026 · ended Jun 30, 2026 · Revenue $125.76M, +11.3% YoY · Filed Aug 7, 2026
Artivion, Inc. (AORT) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $125.8 million and a net loss of $13.5 million. Free cash flow was -$12.0 million. As of Jun 30, 2026 it held $77.3 million in cash and investments and $408.0 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- AORT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Kennesaw, GA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 784199
- Former names
- CRYOLIFE INC (until Jan 6, 2022)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $125.8M | $116.3M | $116.0M | $113.4M | $113.0M |
| Operating income | -$8.4M | $5.8M | $10.7M | $12.5M | $8.4M |
| Net income | -$13.5M | $1.4M | $2.4M | $6.5M | $1.3M |
| Diluted EPS | -$0.28 | $0.03 | $0.05 | $0.13 | $0.03 |
| Operating cash flow | -$1.3M | $1.2M | $19.6M | $22.3M | $15.0M |
| Free cash flow | -$12.0M | -$6.8M | -$7.9M | $17.7M | $11.7M |
| Total assets | $1.1B | $883.2M | $884.8M | $857.7M | $838.4M |
| Total liabilities | $626.3M | $432.7M | $436.6M | $419.0M | $418.5M |
| Stockholders' equity | $445.6M | $450.5M | $448.2M | $438.7M | $419.9M |
| Cash and investments | $77.3M | $55.8M | $64.9M | $73.4M | $53.5M |
| Total debt | $408.0M | $258.2M | $257.6M | $262.0M | $263.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 18, 2026 | May 18, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
All 1001 Artivion, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.